New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Decibel Cannabis Company Inc.
DBCCF
Shape
US Flag

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

15M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

15M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

0.04USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-83%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

69%

Quote Panel

Shape
Updated October 17, 2024
1W -2.76 % 1M -28.71 % 3M -2.63 % 1Y -67.54 %

Key Metrics

Shape
  • Market Cap

    15.21M


  • Shares Outstanding

    409.00M


  • Share in Float

    401.08M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    0.0372


  • Average Volume

    180025


  • Beta

    1.03


  • Range

    0.0278-0.1183


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.decibelcc.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.21x

P/S Ratio

0.49x

P/B Ratio

1.0

Debt/Equity

-3.9%

Net Margin

$-0.0

EPS

How DBCCF compares to sector?

P/E Ratio

Relative Strength

Shape

DBCCF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$104M

Shape369%

2025-Revenue

$0.02

Shape7176%

2025-EPS

$8M

Shape-616%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+598%

0.01
vs -0.00

Q4.22

arrow
arrow

N/A

-0.01
vs 0

Q1.23

arrow
arrow

N/A

-0.00
vs -0.01

Q2.23

arrow
arrow

N/A

-0.00
vs -0.01

Q3.23

arrow
arrow

-93%

0
vs 0.01

Q4.23

arrow
arrow

N/A

-0.00
vs -0.01

Q1.24

arrow
arrow

N/A

-0.01
vs -0.00

Q2.24

arrow
arrow

+127%

0
vs -0.00

Q3.24

arrow
arrow

+412%

0
vs 0

Q4.24

arrow
arrow

+257%

0
vs -0.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+37%

18.3M  vs 13.4M

Q4.22

arrow
arrow

+84%

25.8M  vs 14M

Q1.23

arrow
arrow

+63%

27.1M  vs 16.6M

Q2.23

arrow
arrow

+66%

30.9M  vs 18.6M

Q3.23

arrow
arrow

+65%

30.2M  vs 18.3M

Q4.23

arrow
arrow

+8%

27.7M  vs 25.8M

Q1.24

arrow
arrow

-23%

21M  vs 27.1M

Q2.24

arrow
arrow

-28%

22.2M  vs 30.9M

Q3.24

arrow
arrow

-22%

23.5M  vs 30.2M

Q4.24

arrow
arrow

-11%

24.6M  vs 27.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+10%

0.1
vs -0.05

Q4.22

arrow
arrow

-7%

-0.07
vs 0.1

Q1.23

arrow
arrow

-1%

-0.01
vs -0.07

Q2.23

arrow
arrow

-1%

-0.01
vs -0.01

Q3.23

arrow
arrow

+1%

0.01
vs -0.01

Q4.23

arrow
arrow

-3%

-0.03
vs 0.01

Q1.24

arrow
arrow

-8%

-0.08
vs -0.03

Q2.24

arrow
arrow

+0%

0
vs -0.08

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

DBCCF

prnewswire.com

8 hours ago